デフォルト表紙
市場調査レポート
商品コード
1455194

心血管インプラントの世界市場レポート 2024

Cardiovascular Implants Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
心血管インプラントの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

心血管インプラントの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.6%の年間複合成長率(CAGR)で345億9,000万米ドルに成長すると予想されます。予測期間で予想される成長は、個別化医療アプローチの採用、低侵襲処置への重点、心臓血管調査における世界の協力、予防的介入を重視したヘルスケア政策、患者中心の心臓血管ケアへの移行に起因すると考えられます。予測期間中に予想される主な動向には、薬剤溶出ステントの進歩、次世代心臓弁の台頭、人工知能(AI)の統合の進展、低侵襲植込み技術の重視、個別化された患者専用インプラントの開発、リードレスペースメーカーの出現などがあります。

心臓疾患の有病率の増加が予想されるため、将来、心血管インプラント市場の拡大が促進されると予想されます。心臓障害には、冠状動脈疾患、心不全、不整脈、弁障害など、心臓と血管に影響を及ぼすさまざまな病状が含まれます。ステントやペースメーカーなどの心血管インプラントの需要は、冠状動脈疾患や心不全などの心臓病の蔓延によって促進されており、これらのインプラントはこれらの症状の治療に重要な役割を果たすためです。これらは、心不全患者の心臓と循環をサポートし、規則的な心拍リズムの維持を助け、心臓の活動を監視します。たとえば、2023年4月、英国心臓財団は、スコットランドにおける心臓および循環器疾患による死亡者数が、2020年の17,448人から2021年には17,639人に増加したと報告しました。さらに、英国における冠状動脈性心疾患による死亡者数は、64,170人から増加しました。したがって、心臓疾患の有病率の増加が心血管インプラント市場の成長を促進しています。

高齢化人口の増加は、今後心血管インプラント市場の成長を促進すると予想されます。人口の高齢化は、人口に占める60歳以上の人の割合の増加を特徴とする人口動態の変化を反映しています。 心血管インプラントは、高齢者に蔓延する心血管疾患の管理と治療において重要な役割を果たし、生活の質の向上、寿命の延長、全体的な健康状態の改善に貢献します。 2022年 10月の世界保健機関によると、世界では6人に1人が2030年までに60歳以上になると予測されており、その数は2050年までに21億人に達すると予想されています。したがって、高齢化人口の増加が心血管インプラント市場の成長を促進する重要な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の心血管インプラント市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 冠動脈ステント
  • 植込み型除細動器(ICD)
  • 心臓弁
  • 植込み型心臓ペースメーカー
  • 心臓再同期療法(CRT)装置
  • 末梢ステント
  • 世界の心血管インプラント市場、材料別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 金属および合金
  • ポリマー
  • 生物材料
  • 世界の心血管インプラント市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 不整脈
  • 急性心筋梗塞
  • 心筋虚血
  • その他の用途
  • 世界の心血管インプラント市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 外来手術センター
  • 心臓センター

第7章 地域および国の分析

  • 世界の心血管インプラント市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の心血管インプラント市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 心血管インプラント市場の競合情勢
  • 心血管インプラント市場の企業プロファイル
    • Abbott Laboratories
    • Medtronic PLC
    • Boston Scientific Corporation
    • B. Braun Melsungen AG
    • Edwards Lifesciences Corporation

第31章 その他の主要および革新的な企業

  • WL Gore &Associates Inc.
  • Cook Medical Incorporated
  • Teleflex Incorporated
  • Kyoto Medical Planning Co. Ltd.
  • Abiomed Inc.
  • Livanova PLC
  • BIOTRONIK SE &Co. KG
  • CryoLife Inc.
  • Endologix Inc.
  • Sorin Group
  • Berlin Heart GmbH
  • REVA Medical LLC.
  • Syncardia Systems LLC
  • Elixir Medical Corporation
  • Fortimedix Surgical BV

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r16195

Cardiovascular implants are medical devices surgically placed within the cardiovascular system to manage heart and vascular conditions. These devices are strategically inserted into the cardiovascular system to address conditions such as blocked arteries, irregular heart rhythms, or valve defects. The primary goal is to restore normal heart function and improve blood circulation.

The main types of products categorized under cardiovascular implants include coronary stents, implantable cardioverter defibrillators (ICD), heart valves, implanted cardiac pacemakers, cardiac resynchronization therapy (CRT) devices, and peripheral stents. A coronary stent is a small mesh tube inserted into a narrowed or blocked coronary artery to maintain its openness. Various materials, including metals and alloys, polymers, and biological materials, are used in the manufacturing of these implants. They find applications in treating conditions such as arrhythmias, acute myocardial infarction, myocardial ischemia, and others. These cardiovascular implants are utilized by various end-users, including hospitals, ambulatory surgical centers, and cardiac centers.

The cardiovascular implants market research report is one of a series of new reports from The Business Research Company that provides cardiovascular implants market statistics, including cardiovascular implants industry global market size, regional shares, competitors with a cardiovascular implants market share, detailed cardiovascular implants market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular implants industry. This cardiovascular implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiovascular implants market size has grown strongly in recent years. It will grow from $24.81 billion in 2023 to $26.8 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth observed in the historical period can be attributed to factors such as the aging population and associated cardiovascular risks, lifestyle-related cardiovascular risk factors, advancements in diagnostic technologies, increasing awareness, and screening programs, as well as government initiatives focused on cardiovascular health.

The cardiovascular implants market size is expected to see strong growth in the next few years. It will grow to $34.59 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the forecast period can be attributed to the adoption of personalized medicine approaches, a focus on minimally invasive procedures, global collaboration in cardiovascular research, healthcare policy emphasis on preventive interventions, and the shift towards patient-centric cardiovascular care. Major trends expected in the forecast period include advancements in drug-eluting stents, the rise of next-generation heart valves, increasing integration of artificial intelligence (AI), a focus on minimally invasive implantation techniques, the development of personalized and patient-specific implants, and the emergence of leadless pacemakers.

The anticipated increase in the prevalence of heart disorders is poised to drive the expansion of the cardiovascular implants market in the future. Heart disorders encompass a range of medical conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and valve disorders. The demand for cardiovascular implants, such as stents and pacemakers, is propelled by the prevalence of heart diseases such as coronary artery disease and heart failure, as these implants play a crucial role in treating these conditions. They provide support to the heart and circulation in patients with heart failure, aid in maintaining a regular heart rhythm, and monitor heart activity. For example, in April 2023, the British Heart Foundation reported that the number of deaths in Scotland from heart and circulatory illnesses increased from 17,448 in 2020 to 17,639 in 2021. Moreover, the number of deaths from coronary heart disease in the UK rose from 64,170 in 2020 to 65,579 in 2021. Hence, the growing prevalence of heart disorders is fueling the growth of the cardiovascular implants market.

The increase in the aging population is expected to drive the growth of the cardiovascular implants market in the future. The aging population reflects a demographic shift characterized by a higher proportion of individuals aged 60 and above in a population. Cardiovascular implants play a crucial role in managing and treating cardiovascular diseases prevalent in older individuals, contributing to improved quality of life, increased longevity, and overall better health outcomes. According to the World Health Organization in October 2022, globally, 1 in 6 individuals is projected to be 60 or older by 2030, and this number is expected to reach 2.1 billion elderly people by 2050. Therefore, the rise in the aging population is a key factor driving the growth of the cardiovascular implants market.

The impediment to the growth of the cardiovascular implant market is the high cost associated with left ventricular devices. The incremental cost-effectiveness ratio for destination-therapy left ventricular assist devices (LVAD) over optimal medical management is relatively high. While LVADs improve the quality of life in non-inotrope-dependent heart failure patients, they substantially increase lifetime costs. For example, a study in August 2020 revealed that LVAD patients had higher lifetime costs, with the total cost for the LVAD arm being $551,934 compared to $334,117 for the control group. Consequently, the high cost of left ventricular assist devices poses a restraint on the growth of the cardiovascular implant market.

Leading companies in the cardiovascular implants market are intensifying their focus on incorporating advanced technology, including artificial intelligence (AI), to optimize market profits and enhance precision in patient care and treatment. Advancements in cardiac monitoring technology involve continuous tracking and recording of a patient's heart activity for the diagnosis and management of heart conditions. In June 2023, BIOTRONIK SE & Co. KG launched the BIOMONITOR IV implantable cardiac monitor (ICM), the first globally, combining SmartECG technology with artificial intelligence. This innovation reduces false-positive detections by 86% while retaining 98% accuracy in detecting real episodes. BIOMONITOR IV offers additional benefits, including extended battery life and wireless connectivity for smooth data transmission and remote monitoring, reducing the need for frequent in-person clinic visits.

In April 2023, Abbott Laboratories acquired Cardiovascular Systems Inc. for $890 million, aiming to enhance its solutions for treating vascular disease. This strategic acquisition makes Cardiovascular Systems Inc. a wholly owned subsidiary of Abbott and strengthens Abbott's position in providing innovative solutions for peripheral and coronary vascular disease.

Major companies operating in the cardiovascular implants market report are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Teleflex Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Fortimedix Surgical B.V., AMG International GmbH, CHF Solutions Inc., Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd (Terumo Corporation)

North America was the largest region in the cardiovascular implants market in 2023. The regions covered in the cardiovascular implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiovascular implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiovascular implants market consists of sales of aneurysm stent-grafts, cardiac resynchronization therapy (CRT) devices, ventricular assist devices, and peripheral vascular stents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiovascular Implants Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiovascular implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiovascular implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiovascular implants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Coronary Stent; Implantable Cardioverter Defibrillator (ICD); Heart Valve; Implanted Cardiac Pacemaker; Cardiac Resynchronization Therapy (CRT) Devices; Peripheral Stent
  • 2) By Material: Metals and Alloys; Polymers; Biological Materials
  • 3) By Application: Arrhythmias; Acute Myocardial Infarction; Myocardial Ischemia; Other Applications
  • 4) By End-Users: Hospitals; Ambulatory Surgical Centers; Cardiac Centers
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; B. Braun Melsungen AG; Edwards Lifesciences Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiovascular Implants Market Characteristics

3. Cardiovascular Implants Market Trends And Strategies

4. Cardiovascular Implants Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cardiovascular Implants Market Size and Growth

  • 5.1. Global Cardiovascular Implants Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cardiovascular Implants Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cardiovascular Implants Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cardiovascular Implants Market Segmentation

  • 6.1. Global Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Coronary Stent
  • Implantable Cardioverter Defibrillator (ICD)
  • Heart Valve
  • Implanted Cardiac Pacemaker
  • Cardiac Resynchronization Therapy (CRT) Devices
  • Peripheral Stent
  • 6.2. Global Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Metals and Alloys
  • Polymers
  • Biological Materials
  • 6.3. Global Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Arrhythmias
  • Acute Myocardial Infarction
  • Myocardial Ischemia
  • Other Applications
  • 6.4. Global Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers

7. Cardiovascular Implants Market Regional And Country Analysis

  • 7.1. Global Cardiovascular Implants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cardiovascular Implants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cardiovascular Implants Market

  • 8.1. Asia-Pacific Cardiovascular Implants Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cardiovascular Implants Market

  • 9.1. China Cardiovascular Implants Market Overview
  • 9.2. China Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cardiovascular Implants Market

  • 10.1. India Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cardiovascular Implants Market

  • 11.1. Japan Cardiovascular Implants Market Overview
  • 11.2. Japan Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cardiovascular Implants Market

  • 12.1. Australia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cardiovascular Implants Market

  • 13.1. Indonesia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cardiovascular Implants Market

  • 14.1. South Korea Cardiovascular Implants Market Overview
  • 14.2. South Korea Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cardiovascular Implants Market

  • 15.1. Western Europe Cardiovascular Implants Market Overview
  • 15.2. Western Europe Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cardiovascular Implants Market

  • 16.1. UK Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cardiovascular Implants Market

  • 17.1. Germany Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cardiovascular Implants Market

  • 18.1. France Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cardiovascular Implants Market

  • 19.1. Italy Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cardiovascular Implants Market

  • 20.1. Spain Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cardiovascular Implants Market

  • 21.1. Eastern Europe Cardiovascular Implants Market Overview
  • 21.2. Eastern Europe Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cardiovascular Implants Market

  • 22.1. Russia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cardiovascular Implants Market

  • 23.1. North America Cardiovascular Implants Market Overview
  • 23.2. North America Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cardiovascular Implants Market

  • 24.1. USA Cardiovascular Implants Market Overview
  • 24.2. USA Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cardiovascular Implants Market

  • 25.1. Canada Cardiovascular Implants Market Overview
  • 25.2. Canada Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cardiovascular Implants Market

  • 26.1. South America Cardiovascular Implants Market Overview
  • 26.2. South America Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cardiovascular Implants Market

  • 27.1. Brazil Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cardiovascular Implants Market

  • 28.1. Middle East Cardiovascular Implants Market Overview
  • 28.2. Middle East Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cardiovascular Implants Market

  • 29.1. Africa Cardiovascular Implants Market Overview
  • 29.2. Africa Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cardiovascular Implants Market Competitive Landscape And Company Profiles

  • 30.1. Cardiovascular Implants Market Competitive Landscape
  • 30.2. Cardiovascular Implants Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Medtronic PLC
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Boston Scientific Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. B. Braun Melsungen AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Edwards Lifesciences Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cardiovascular Implants Market Other Major And Innovative Companies

  • 31.1. W. L. Gore & Associates Inc.
  • 31.2. Cook Medical Incorporated
  • 31.3. Teleflex Incorporated
  • 31.4. Kyoto Medical Planning Co. Ltd.
  • 31.5. Abiomed Inc.
  • 31.6. Livanova PLC
  • 31.7. BIOTRONIK SE & Co. KG
  • 31.8. CryoLife Inc.
  • 31.9. Endologix Inc.
  • 31.10. Sorin Group
  • 31.11. Berlin Heart GmbH
  • 31.12. REVA Medical LLC.
  • 31.13. Syncardia Systems LLC
  • 31.14. Elixir Medical Corporation
  • 31.15. Fortimedix Surgical B.V.

32. Global Cardiovascular Implants Market Competitive Benchmarking

33. Global Cardiovascular Implants Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cardiovascular Implants Market

35. Cardiovascular Implants Market Future Outlook and Potential Analysis

  • 35.1 Cardiovascular Implants Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cardiovascular Implants Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cardiovascular Implants Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer